Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds



Researchers from Heidelberg Medical Faculty, Heidelberg University Hospital and German Cancer Research Center investigate molecular relationships that promote infection and spread of SARS- coronavirus-2 / Results provide starting point for development of antiviral therapies

The SARS-coronavirus-2, responsible for the COVID-19 pandemic, triggers a stress response in infected cells that facilitates the virus' entry into the cells. In their search for the underlying molecular mechanism, researchers from the Heidelberg University Medical School and Heidelberg University Hospital (UKHD), in collaboration with the German Cancer Research Center (DKFZ) and the University of Bristol, identified a cellular factor called NUAK2. Its amount is increased by the SARS-CoV-2 mediated cellular stress response and it promotes the entry and spread of the coronavirus in human cells. Thus, NUAK2 could be a new target for the development of antiviral agents.

The research team led by Professor Dr. Dr. h.c. Ralf Bartenschlager, Head of the Division of Molecular Virology at the Center for Infectious Diseases at UKHD and Dr. Vibhu Prasad, Scientist in Molecular Virology has now analyzed the molecular pathways involved in SARS-CoV-2 infection of the cell. The cellular protein NUAK2 plays a central role in this process.

The Heidelberg scientists blocked NUAK2 in the cells and observed reduced infection of cells by SARS-CoV-2 particles. In subsequent studies, the scientists found that NUAK2 regulates the amount of ACE2, the receptor for the virus, on the cell surface. "In addition, our studies showed that increased NUAK2 levels in infected cells increased the number of receptors in uninfected cells as well. As a result, these cells also became more infected with SARS-CoV-2," reports Dr. Vibhu Prasad.

And these correlations could be demonstrated not only with SARS-CoV-2, but also with other coronavirus species such as human coronavirus-229E - a "common cold virus" - and the very dangerous MERS coronavirus, which can be transmitted from camels to humans.

"The research findings provide valuable insights into the intricate mechanisms of SARS-CoV-2 infection and spread. Understanding the role of NUAK2 opens new avenues for therapeutic intervention. By interrupting NUAK2-regulated virus entry, we might be able to prevent the spread of the virus and thereby mitigate the effects of coronavirus infections," says Professor Ralf Bartenschlager.

 Prasad V, Cerikan B, Stahl Y, et al. Enhanced SARS-CoV-2 entry via UPR-dependent AMPK-related kinase NUAK2 [published online ahead of print, 2023 Jun 29]. Mol Cell. 2023;S1097-2765(23)00467-7. doi:10.1016/j.molcel.2023.06.020



Newly funded research network CoViPa (Corona Virus Pathogenesis)

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has major global impact on human society, economy and daily life. Inspite of rapid progress in this field, the molecular determinants underlying COVID-19 pathogenesis remain unclear.

To gain knowledge about the virological and immunological drivers of COVID-19 pathogenesis and the parameters of immune protection, we united experts from 7 Helmholtz Centers and 3 university partners, to create an internationally competitive and interdisciplinary network called CoViPa that pursues two major goals:

  1. Determine the virological and immunological parameters underlying COVID-19 pathogenesis to define targeted therapies and inform vaccine development;
  2. Use SARS-CoV-2 as paradigm to gather knowledge and establish durable technology platforms for pandemic preparedness.

CoViPa is coordinated by the Helmholtz Association and comprises 21 principal investigators that are leaders in field.


The Helmholtz campaign "The Coronavirus Pandemic: Insight, Coping, and Prevention" (in German):


to top
powered by webEdition CMS